2437 related articles for article (PubMed ID: 8381684)
1. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
2. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
Liu H
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
[TBL] [Abstract][Full Text] [Related]
3. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
4. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
5. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
Gupta KC; Agha R; Santos E; Brodeur BR
Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
[TBL] [Abstract][Full Text] [Related]
8. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC
Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies to nuclear antigens.
McKnight ME; Koda K; DeBoer K; Glassy MC
Hum Antibodies Hybridomas; 1990; 1(2):77-82. PubMed ID: 2103355
[TBL] [Abstract][Full Text] [Related]
12. Determination of the optimal human cell lines for development of human hybridomas.
Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
14. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
15. Immortalization of human lymphocytes from a tumor-involved lymph node.
Glassy MC
Cancer Res; 1987 Oct; 47(19):5181-8. PubMed ID: 3621203
[TBL] [Abstract][Full Text] [Related]
16. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
17. An IgG human monoclonal antibody reactive with a surface membrane antigen expressed on malignant breast cancer cells.
Posner MR; Elboim HS; Tumber MB; Wiest PM; Tibbetts LM
Hum Antibodies Hybridomas; 1991 Apr; 2(2):74-83. PubMed ID: 1651787
[TBL] [Abstract][Full Text] [Related]
18. [Human monoclonal antibodies with human-mouse hybridomas].
Naoe T; Kato K; Shiku H; Yamada K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B].
Chen Q; Cao H; Zhang HY; Gao XF; Wang F; Li HD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):556-8. PubMed ID: 17553354
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
